Year in Review

Year in Review Uveitis

Year in Review: Uveitis

Take a look back at the most popular Uveitis articles of 2016


VIDEO: Discussion of Prescribing Practices for Uveitis

Allan Gibofsky, MD, attending rheumatologist and Co-director of the Clinic for Inflammatory Arthritis at Hospital for Special Surgery, in New York City, met with Rheumatology Advisor to discuss the recent approval of adalimumab for noninfectious uveitis.
eye anatomy

Looking Beyond Corticosteroids to Treat Noninfectious Uveitis

The recent US Food and Drug Administration (FDA) approval of adalimumab (Humira®, AbbVie) for the treatment of noninfectious intermediate, posterior, and pan-uveitis is the first step beyond traditional corticosteroid therapy and toward use of targeted biologics for this rare ocular emergency.